Restricted accessResearch articleFirst published online 2022-12-23
Iron supplementation in pregnant Danish women revisited: Effects on prepartum and postpartum iron deficiency,anemia,serum erythropoietin;including iron status,erythropoietin and anthropometrics in newborns. A randomized,placebo-controlled study
To assess effects of iron supplementation, 66 mg elemental iron daily as ferrous fumarate, on iron status markers during normal pregnancies.
METHODS:
Randomized, double-blind, placebo-controlled study of 119 women (62 iron-, 57 placebo -treated) and their newborns. Hemoglobin (Hb), serum (S)-ferritin, S-transferrin saturation percentage (TSAT) and S-erythropoietin (S-EPO) were measured at 14–18, 24–27 weeks of gestation, prepartum, 1 and 8 weeks postpartum.
RESULT:
From 24–27 weeks gestation to 8 weeks postpartum, the iron group had higher Hb, S-ferritin and TSAT than the placebo group; prepartum, 11% had iron deficiency (ID) and 0% iron deficiency anemia (IDA) in the iron group, vs 60% and 18% in the placebo group; 8 weeks postpartum 1.6% in the iron group had ID and 1.6% IDA vs 14% and 7% in the placebo group. S-EPO levels in the iron group were lower than in the placebo group (p < 0.001). Mothers prepartum S-EPO values were correlated to newborns cord S-EPO values (p < 0.001). Newborns to iron treated mothers had higher cord S-ferritin levels than those to placebo treated mothers (p = 0.02). Newborn girls had higher cord S-ferritin levels than boys (p < 0.01). There was no impact of iron supplementation on the length of gestation, placental weight, or newborns birth weight. Birth weight was correlated only with mothers’ body weight, length of gestation and placental weight.
CONCLUSION:
Iron supplementation had a “positive” impact on iron status and Hb both during pregnancy and postpartum, with a low frequency of ID/IDA and also a “positive” influence on newborns iron status.
BothwellTH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr. 2000;72:257S–264S.
2.
MilmanN. Iron and pregnancy –a delicate balance. Ann Hematol. 2006;85:559–565.
3.
MilmanN. Iron in pregnancy –how do we secure an appropriate iron status in the mother and child. Ann Nutr Metab. 2011;59:50–54.
4.
MilmanN, BygK-E, OvesenL. Iron status in Danes updated II. Prevalence of iron deficiency and iron overload in women aged 40-70 years: Influence of blood donation, alcohol intake, and iron supplementation. Ann Hematol. 2007;79:612–621.
5.
MilmanN, TaylorCL, MerkelJ, BrannonPM. Iron status in pregnant women and women of reproductive age in Europe. Am J Clin Nutr. 2017;106(Suppl):1655S–1662S.
6.
MilmanNT. Dietary iron intake in pregnant women in Europe: A review of 24 studies from 14 countries in the period 1991-2014. J Nutr Metab. 2020;2020:11. Article ID 7102190.
7.
MilmanN. Oral iron prophylaxis in pregnancy: Not too little and not too much! Journal of Pregnancy, Special issue: Anemia and iron deficiency in pregnancy. J Pregnancy. 2012;2012:8. Article ID 514345.
8.
MilmanN, AggerAO, NielsenOJ. Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. Dan Med Bull. 1991;38:471–476.
BarnardDF, CarterAB, Crosland-TaylorBJ, StewartJW. An evaluation of the Counter model S®. J Clin Pathol. 1969;(suppl 2-3):26–33.
11.
MilmanN, GraudalN, Juul-JørgensenB, BentzonMW. Calibration of the amersham ferritin RIA® kit using the WHO human liver ferritin international standard 80/602. Eur J Clin Chem Clin Biochem. 1994;32(1):41–42.
12.
NielsenOJ. Determination of human erythropoietin by radioimmunoassay. Method and clinical data. Clin Chim Acta. 1988;176:303–313.
13.
MilmanN, IbsenKK, ChristensenJM. Serum ferritin and iron status in mothers and newbom infants. Acta Obstet Gynecol Scand. 1987;66:205–211.
14.
MilmanN, PedersenNS, VisfeldtJ. Serum ferritin in healthy Danes: Relation to marrow haemosiderin iron stores. Dan Med Bull. 1983;30:115–120.
15.
WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO
16.
MilmanN, BygK-E, GraudalN, AggerAO. Reference values for hemoglobin and erythrocyte indices during normal pregnancy in 206 women with and without iron supplementation. Acta Obstet Gynecol Scand. 2000;78:89–98.
17.
MilmanN, BergholdtT, BygK-E, EriksenL, HvasA-M. Reference intervals for haematological variables during normal pregnancy and postpartum in 433 healthy Danish women. Eur J Haematol. 2007;79:39–46.
18.
World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011 (WHO/NMH/ NHD/MNM/11.1)
19.
ElsayedME, SharifMU, StackAG. Chapter four - transferrin saturation: A body iron biomarker. Adv Clin Chem. 2016;75:71–97.
20.
MilmanN, BergholtT, EriksenL, BygK-E, GraudalN, PedersenP, HertzJ. Iron prophylaxis during pregnancy - how much iron is needed? A randomized dose-response study of 20-80 mg ferrous iron daily in pregnant women. Acta Obstet Gynecol Scand. 2005;84:238–247.
21.
MilmanNT. Dietary iron intake in women of reproductive age in europe: A review of 49 studies from 29 countries in the period 1993–2015. J Nutr Metab. 2019:13. Article ID 7631306.
22.
Danish National Board of Health. Recommendations about iron supplementation during pregnancy. Ugeskr Laeger. 1992;154:3445.
23.
BodnarLM, CogswellME, ScanlonKS. Low income postpartum women are at risk of iron deficiency. J Nutr. 2002;132:2298–2302.
24.
SchneiderH, MalekA. Lack of permeability of the human placenta for erythropoietin. J Perinat Med. 1995;23:71–76.
25.
DavisLE, WidnessJA, BraceRA. Renal and placental secretion of erythropoietin during anemia or hypoxia in the ovine fetus. J Obstet Gynecol. 2003;189:1764–70.
26.
MoritzKM, LimGB, WintourEM. Developmental regulation of erythropoietin and erythropoiesis. Invited review. Am J Physiol. 1997;R1829–R1844.
27.
LorenzL, PeterA, ChristianF, PoetsCF, FranzAR. A Review of cord blood concentrations of iron status parameters to define reference ranges for preterm infants. Neonatology. 2013;104:194–202.
28.
MilmanN, BygK-E, HvasA-M, BergholtT, EriksenL. Erythrocyte folate, plasma folate and plasma homocysteine during normal pregnancy and postpartum: A longitudinal study comprising 404 Danish women. Eur J Haematol. 2006;76:200–5.
29.
CzeizelAE, DudásI, VereczkeyA, BánhidyF. Folate deficiency and folic acid supplementation: The prevention of neural-tube defects and congenital heart defects. Nutrients. 2013;5(11):4760–4775.
30.
BeardJ. Iron deficiency alters brain development and functioning. J Nutr. 2003;133(5 Suppl 1):1468S–1472S.
31.
LozoffB. Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction. J Nutr. 2011;141(4):740S–746S.
32.
MilmanN, JønssonL, DyreP, PedersenPL, LarsenLG. Ferrous bisglycinate 25mg iron is as effective as ferrous sulfate 50mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial. J Perinat Med. 2014;42:197–206.
33.
SiddappaAM, RaoR, LongJD, WidnessJA, GeorgieffMK. The assessment of newborn iron stores at birth: A review of the literature and standards for ferritin concentrations. Neonatology. 2007;92(2):73–82.
34.
de ZegherF, DevliegerH, EeckelsR. Fetal growth: Boys before girls. Horm Res. 1999;51(5):258–259.
35.
WiegersmaAM, DalmanC, LeeBK, KarlssonH, GardnerRM. Association of prenatal maternal anemia with neurodevelopmental disorders. JAMA Psychiatry. 2019;76(12):1294–1304.
36.
InselBJ, SchaeferCA, McKeagueIW, SusserES, BrownAS. Maternal iron deficiency and the risk of schizophrenia in offspring. Arch Gen Psychiatry. 2008;65(10):1136–1144.
37.
SørensenHJ, NielsenPR, PedersenCB, MortensenPB. Association between prepartum maternal iron deficiency and offspring risk of schizophrenia: Population-based cohort study with linkage of Danish national registers. Schizophr Bull. 2011;37(5):982–987.
